Cart
sales@molnova.com
HA14-1
CAS No. 65673-63-4
HA14-1 ( HA-14-1;HA 14-1 )
Catalog No. M15498 CAS No. 65673-63-4
HA14-1 a small molecule, nonpeptidic Bcl-2 antagonist that binds Bcl-2 surface pocket with binding IC50 of 9 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 35 | In Stock |
|
| 25MG | 56 | In Stock |
|
| 50MG | 80 | In Stock |
|
| 100MG | 115 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHA14-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionHA14-1 a small molecule, nonpeptidic Bcl-2 antagonist that binds Bcl-2 surface pocket with binding IC50 of 9 uM.
-
DescriptionHA14-1 a small molecule, nonpeptidic Bcl-2 antagonist that binds Bcl-2 surface pocket with binding IC50 of 9 uM, induces apoptosis of tumor cells; effectively induces apoptosis of HL-60 cells overexpressing Bcl-2 protein associated with the decrease in mitochondrial membrane potential and activation of caspase-9 followed by caspase-3; strongly induces the death of NIH 3T3 (Apaf-1(+/+)) cells.
-
SynonymsHA-14-1;HA 14-1
-
PathwayAngiogenesis
-
TargetBcl-2
-
RecptorBcl-2
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number65673-63-4
-
Formula Weight409.23
-
Molecular FormulaC17H17BrN2O5
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(C1=C(N)OC2=C(C=C(Br)C=C2)[C@H]1[C@H](C#N)C(OCC)=O)OCC
-
Chemical Name4H-1-Benzopyran-4-acetic acid, 2-amino-6-bromo-.alpha.-cyano-3-(ethoxycarbonyl)-, ethyl ester, (.alpha.R,4R)-rel-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wang JL, et al. Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7124-9.
2. Milella M, et al. Blood. 2002 May 1;99(9):3461-4.
3. Chen J, et al. Mol Cancer Ther. 2002 Oct;1(12):961-7.
4. Lickliter JD, et al. Leukemia. 2003 Nov;17(11):2074-80.
2. Milella M, et al. Blood. 2002 May 1;99(9):3461-4.
3. Chen J, et al. Mol Cancer Ther. 2002 Oct;1(12):961-7.
4. Lickliter JD, et al. Leukemia. 2003 Nov;17(11):2074-80.
molnova catalog
related products
-
AZD 4320
AZD4320 is a BH3 mimetic and dual Bcl-2/Bcl-XL inhibitor with IC50 of <1 nM.
-
17-Hydroxy sprengeri...
17-Hydroxy sprengerinin C is a glycoside compound isolated from rhizomes of Polygonatum sibiricum with stronger anticancer activities.
-
TG003
TG003 is a potent and ATP-competitive Cdc2-like kinase (Clk) inhibitor with IC50 of 20 nM, 200 nM, and 15 nM for Clk1, Clk2, and Clk4, respectively.
